Workflow
国际化医疗合作
icon
Search documents
丽滋卡尔海南梅赛尔医院加入妙佑医疗联盟
Sou Hu Cai Jing· 2025-07-20 09:35
妙佑医疗国际(Mayo Clinic)是全球规模最大的综合性非营利医生执业组织,被誉为当今最负盛名、最具竞争力 和生命力的世界顶级综合性高端医疗服务品牌,成立至今已为全球超六百万人进行治疗服务,患者包括欧洲王 室、中东富豪、欧美政要、社会名流等各界人士。 加入妙佑医疗联盟后,梅赛尔医院将深度整合妙佑医疗国际百年积淀的临床经验与创新成果,实现诊疗标准国际 化、专家会诊国际化、转诊通道全球化的三大核心升级,以及精准医疗触手可及、无缝衔接国际专家、全流程健 康管理和以患者为中心的全周期健康守护升级。妙佑医疗国际相关负责人表示:"梅赛尔医院在预防医学、康复及 慢性病管理方面的持续推进,与妙佑的价值理念高度契合。我们非常荣幸地欢迎丽滋卡尔海南梅赛尔医院加入妙 佑医疗联盟。"丽滋卡尔总裁刘向丽表示:"成为妙佑医疗联盟的一员是丽滋卡尔'无界医疗'理念的具体实践。我 们不仅引进了先进的医疗技术,更重要的是融入了妙佑'以患者为中心'的服务价值观,让我们的会员无需出国门 即可享受到世界级的医疗服务。" 未来,丽滋卡尔将持续拓展与癌研有明医院、瑞士SGK等国际伙伴的合作,加快GAEA康养集群的建设速度,不 断完善"防-治-养-护" ...
跨国携手谋新篇 妙佑医疗国际同美中嘉和、石药集团共谋国际化合作
Zheng Quan Ri Bao Wang· 2025-04-17 11:45
Core Insights - The event held at Shijiazhuang Edison Oncology Hospital from April 13 to 15, 2025, aimed to integrate international medical concepts with local healthcare needs, featuring representatives from Mayo Clinic, Meizhong Jiahe Medical Technology Development Group, and Shijiazhuang Edison Oncology Hospital [1][2][3][4] - The collaboration is expected to enhance the hospital's development in oncology care by adopting advanced international medical practices and management strategies [1][2][3] Group 1: International Collaboration - Mayo Clinic's team, led by Dr. Brian Costello, emphasized the importance of international medical cooperation in addressing cancer challenges and expressed hopes for a close partnership to improve cancer care globally [2][3] - Meizhong Jiahe has been collaborating with Mayo Clinic since 2020, implementing advanced management models and treatment techniques in its Guangzhou Taihe Oncology Hospital, which received positive feedback from the industry and patients [3] - The partnership aims to enhance the influence of Meizhong Jiahe in the international oncology market by aligning with Mayo Clinic's expertise in oncology [3] Group 2: Local Healthcare Development - Shijiazhuang Edison Oncology Hospital's General Manager, Pang Shizhen, highlighted the visit as a significant opportunity to adopt international healthcare models, potentially leading to transformative growth in oncology services [1] - Stone Pharmaceutical Group's Executive President, Zhen Hong, noted the alignment of both organizations' missions to improve global health, focusing on areas like new drug development and clinical trials [4] - Discussions during the event covered various topics, including patient needs, service capabilities, and best practices in clinical staffing, aiming to establish a solid foundation for future collaborations [4]